胸腺癌 SCIE

期刊简介预计审稿时间： 约2月

Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies. Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed. The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer. Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.

The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.

《胸腔癌》旨在促进肺癌、食道癌、纵隔癌、乳腺癌和其他胸部恶性肿瘤的基础、转化和应用临床研究方面的国际合作和全面前沿信息的交流。亚太地区的预防、治疗和研究是重点领域，但欢迎所有地区的投稿。编辑鼓励投稿涉及预防、普通胸外科、肿瘤内科、放射学、放射医学、病理学、基础癌症研究以及胸腔癌的流行病学和转化研究。 《胸部肿瘤》是中华医学会肺癌分会、国际华人胸外科学会的官方刊物，并得到韩国肺癌研究协会和香港癌症治疗学会的认可。

该期刊发表多种类型的文章，包括：社论、特邀评论、迷你评论、原创文章、临床指南、技术说明、胸部肿瘤影像、会议报告、病例报告、致编辑的信、评论和简要报告。

《Thoracic Cancer》(胸腺癌)编辑部通讯方式为111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。